We've been working on animal diseases for 45 years and we made a number of coronavirus vaccines that were licensed and commercialized for other species. When SARS-1 came, we were part of the Canadian accelerated vaccine initiative at the time. We were just doing research on MERS before the pandemic hit, so we have a lot of expertise in working on these viruses. As you know, they affect animals and humans. We live in a one health world. We have a lot of expertise working with these, and that was really the reason our vaccine went forward so quickly.
On February 16th, 2021. See this statement in context.